ABA Program on Nano Governance

Presenting what looks to be a very interesting line-up of top-rate speakers, the American Bar Association's Section of Environment, Energy, and Resources (Pesticides, Chemical Regulation, and Right-to-Know Committee) is presenting a webinar on January 27, 2011:

Nano Governance: The Current State of Federal, State, and International Regulation

Here is a summary of the webinar from ABA's online announcement:

States, federal agencies, and foreign governments are challenged to address the risks and promote the benefits of evolving technologies, including nanotechnology. Companies globally are continuing to harness the properties of nanomaterials for use in products from airplanes to pharmaceuticals and from cosmetics to food packaging. Nano Governance: The Current State of Federal, State, and International Regulation will address these issues in a half-day program. This program will explore the new and creative applications of existing regulatory tools and governance approaches to address the potential risks of nanotechnologies, implement new risk assessment approaches to evolving technologies, and maximize the potential benefits of these materials. Panelists will report on new and emerging federal, State, and international nanomaterials regulations and governance strategies. Attendees will gain insight into potential public health and environmental impacts and the approaches various government agencies and industrial stakeholders are pursuing to address these issues while also promoting nanotechnology. The program is open to attorneys and other professionals with chemical regulatory compliance practices.

Educational Objectives:

  • Develop familiarity with new and emerging federal, State, and international nanomaterials regulations and governance strategies
  • Understand Potential Public Health and Environmental Impacts and the approaches various government agencies are pursuing to promote nanotechnology while also addressing potential public health and environmental risks
  • Appreciate complexities of addressing potential risks with existing governance tools and strategies while also embracing new approaches to accommodate evolving technologies

I hope to attend by telephone and encourage any interested readers to do the same.  It should be a great conference.

 

New Nano-specific Regulations Forthcoming from U.S. EPA

This article originally appeared on the National Nanomanufacturing Network's InterNano website. It is licensed under Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported.

In its ongoing efforts to guard against potential unintended environmental, health, or safety injuries related to possible exposure to certain nanoscale materials, the US Environmental Protection Agency (EPA) plans to issue three new proposed nano-specific regulations in January 2011. While EPA is already actively regulating certain nanoscale materials which it considers new chemical substances (e.g./ carbon nanotubes, fullerenes, etc.), the new proposed rules will provide EPA with greater latitude in regulating both new and existing nanoscale materials. Manufacturers working with nanoscale materials should keep a very close eye on these new proposed regulations to determine whether they will be required to comply with any of EPA's final rulings. Additionally, there will be opportunities for public comment and input.

Significant New Use Rule

Advocacy groups have been asking EPA for years to treat nanoscale versions of existing chemical substances as significant new uses of those substances under the Toxic Substances Control Act (TSCA). These types of substances include nanoscale silver, nanoscale TiO2, and nanoscale zinc oxide. Among other things, treating these materials as significant new uses of existing chemical substances would allow EPA to limit their production, require the use of workplace safety measures, require companies to conduct toxicity testing, and require companies to prevent intentional/purposeful releases of the materials to water.

Although its exact parameters have not been released, it appears that EPA intends to issue a proposed significant new use rule under Section 5 of TSCA in January 2011 addressing these issues. While the contours of the rule are difficult to predict, a likely tactic may be to "grandfather in" nanoscale versions of existing chemical substances, but to treat any new attempts to manufacture or use nanoscale versions of existing chemical substances as significant new uses. While such an approach will likely to draw complaints from “newcomers” because companies already manufacturing in the niche would have a distinct competitive advantage, it might be the only workable approach available to EPA. It is virtually impossible to catalogue all existing uses of each nanoscale material already in the marketplace.

Testing Rule

While EPA is already requiring rigorous 90 day in vivo inhalation toxicity testing for certain new nanoscale materials, it appears that the Agency intends to propose a testing rule under Section 4 of TSCA in January 2011 requiring this same type of testing for certain nanoclays, nanoscale aluminum oxide, and nanotubes. Nanoclays and nanoscale aluminum oxide were apparently considered because no country volunteered to be lead sponsor for their testing under the Organization for Economic Cooperation and Development's comprehensive toxicity testing program. Additionally, no manufacturers have submitted premanufacturing notices for nanoclays un the U.S. which might otherwise provide EPA with the chance to require similar testing.

Conducting a 90 day in vivo inhalation test on a nanoscale material is difficult and can cost between $350,000 to $500,000 for each material tested. It will be interesting to see whether EPA’s proposed testing rule will allow for joint testing by manufacturers in order to reduce cost and increase efficiency. At least one group of manufacturers -- the NanoSafety Consortium for Carbon -- is already preparing to ask EPA to use this approach with their nanoscale carbon materials.

Data Collection Rule

Perhaps the broadest proposed rule EPA intends to issue in January 2011 will require manufacturers of nanoscale substances which have not already made formal detailed submissions to EPA to submit detailed EHS data for EPA’s review and consideration. The new proposed rule will be issued under Section 8(a) of TSCA, and will essentially make EPA's prior voluntary Nanoscale Materials Stewardship Program (NMSP) into a mandatory data collection effort. Readers may recall that the NMSP program received lukewarm industry participation, which is apparently resulting in the new mandatory approach.

Fortunately, the TSCA provision authorizing such data-call-ins allows manufacturers to apply to EPA for exemptions in instances where the subject nanoscale materials are only manufactured in small quantities (less than 500 kgs) or are being made solely for research and development purposes.

Finally, for those who might be interested, Section 8(a) of TSCA allows EPA to request information regarding:

  • The common or trade name, the chemical identity, and the molecular structure of each chemical substance or mixture.
  • The categories or proposed categories of use of each such substance or mixture.
  • The total amount of each such substance and mixture manufactured or processed, reasonable estimates of the total amount to be manufactured or processed, the amount manufactured or processed for each of its categories of use, and reasonable estimates of the amount to be manufactured or processed for each of its categories of use or proposed categories of use.
  • A description of the byproducts resulting from the manufacture, processing, use, or disposal of each such substance or mixture.
  • All existing data concerning the environmental and health effects of such substance or mixture.
  • The number of individuals exposed, and reasonable estimates of the number who will be exposed, to such substance or mixture in their places of employment and the duration of such exposure.
  • The manner or method of its disposal, and in any subsequent report on such substance or mixture, any change in such manner or method.

 

Nanotechnology Insurance Issues

For anyone who might be interested, I will be speaking on nano-related insurance issues at the opening plenary of the National Nanotechnology Initiative's upcoming Oct. 6 -7 conference and workshop on Nanomaterials and the Environment & Instrumentation.  The draft agenda for the conference can be found here, and the plenary is also supposed to be broadcast on the web.  I will post the information for the simulcast as we get closer to the conference date.  Cost, location, and registration info. is here.

Spheres of Influence

The April issue of Environmental Health Perspectives carried an interesting article by Charles W. Schmidt,  "Nanotechnology Related Environment, Health, and Safety Research: Examining the National Strategy". The article looks at what could be a disturbing development, that

Experts in nanotoxicity and risk assessment have become increasingly polarized, represented on one side by the National Research Council (NRC) and on the other by the National Nanotechnology Initiative (NNI).

Schmidt's article notes that this polarization began after the Nanotechnology Environmental And Health Implications (NEHI) Working Group, part of NNI, released Strategy for Nanotechnology Related Environmental Health and Safety Research in February 2008. The report presented the then Bush Administration's agenda for studying nanoparticle hazards and was developed and written after "extensive consultations with regulatory agencies, research organizations, the business community and non-governmental organizations". The report reflected the concerns of the established stakeholders in nanotechnology.

In February 2009, an NRC assembled panel released its own report

. . .  describing what it calls serious short comings in the strategy document. According to the NRC panel . . . the strategy exposes weaknesses in the government's understanding of potential nanotechnology risks today and doesnot adequately address how they will be assessed in the future.

. . . NRC panelists would like to see a National Health based Strategy for nanotechnology research with defined goals, milestones, and mechanisms for assessing progress. . . . The need isn't just to insure the safety of nano-enabled products, but also to avert a public backlash against the technology, which could grow if health risks aren't seen as adequately addressed.

. . . The NNI strategy document - NRC panelists claim - is simply a compendium of federally funded projects without any unifying vision or sense of shared purpose.

An advance copy of the NRC report leaked out to the press in December 2008, leading NNI to post a rebuttal on its website , presenting the strategy document not an implementation plan, "But rather a higher-level description of the inter-agency approach to nanotechnology related EHS research."

One can only hope that the growing divide can be bridged. Both sides have much to contribute to the future growth of nanotechnology and a split into opposing camps serves neither side very well.

The final part of this article turns toward a different, in many ways more worrisome, topic. In January 2008, the EPA launched its nanoscale materials voluntary stewardship program, which urged companies to report information to EPA about their use, manufacture, import, etc of nanoparticles; according to the article, as of January 2009, only 29 companies had responded.

While companies might fear that their trade secrets might be revealed to competitors, it is more likely that what companies are afraid of are potential product liability lawsuits, legitimate or not, that would keep them in court for years (the shadow of asbestos again) and giving information to groups that would use the general public lack of understanding of nanotechnology - to most people, this is still science fiction - to create a climate of fear. At this stage in its development, the nanoindustry might be compared to the nuclear industry from 1950 until the mid-1980s. For the general public in that period, nuclear power was a mysterious thing beyond the non-scientist's ability to understand. For most people, nuclear energy meant only one thing: the power to destroy, personified in the form of Godzilla. Interest groups opposed to the further development of nuclear energy were able to use companies involved in the construction and running of nuclear power plants unwillingness to provide the public with information to create an effective climate of fear and opposition to the point where the industry nearly shut down after 3 Mile Island and Chernobyl.

To avoid this fate

. . .  nanoparticle toxicity data need to be made more widely available to insure public support for the technology.

rather than burying the information in annual reports or SEC filings, such as a 10K or a 10Q, which, while they are great sources of information, are also usually great cures for insomnia.

In an age of calls for greater transparency in both government and business, one can only hope that the nanoindustry will seize the moment and release more information in a form and language that the general public can understand. As someone once observed, sunshine is the best disinfectant.

 

 

Nanotechnology Law Report -- Spring 2009

Nanotechnology Standards for Health, Safety, and Environmental Factors

This Article Was Authored and Contributed by the American National Standards Intititute

This second article in a series on nanotechnology standardization introduces the international working group that, under US leadership, is creating the standards needed to support the health, safety, and environmental aspects of nanotechnology.


In the post-war era of the late 1940s, global leaders of government and industry formed a central body to “facilitate the international coordination and unification of industrial standards.” Twenty-six member nations came together in 1947 to form the International Organization for Standardization (ISO). 

 

ISO and its national member bodies – including the American National Standards Institute (ANSI) – are constantly evolving to meet changing demands. Today, ISO is addressing issues such as industrialization, the advancement of information technologies, quality, the environment, and the health and safety of workers and consumers. Today, roughly one of every twenty ISO standards addresses issues pertaining to health, safety or the environment.

In June 2005, ISO formed a new Technical Committee to help focus the world’s attention on standards that would support the growth of nano-related industries. The scope of that committee, ISO/TC 229 – Nanotechnologies, includes standardization in the areas of terminology and nomenclature; measurement and instrumentation; material specifications; and health, safety and the environment. The standards that are being created by this Committee can be utilized by national bodies to support regulatory activity within nanotechnology development, which in turn supports workers that encounter nanotechnologies on the job.

As new materials, structures, devices and systems are developed that derive their properties and function due to their nanoscale dimensions, standards act to enhance the development of these technologies by encouraging cooperation and collaboration in the industry. Bringing experts together for the purpose of standardization promotes the best uses and highest functioning of nanotechnology across the wide range of industries that it affects.

“Standards are important for supporting research aimed to safely develop and apply nanotechnology for societal benefit and economic growth,” said Clayton Teague, director of the National Nanotechnology Coordination Office, Executive Office to the President of the United States. “Standards are equally important for research aimed to better protect public health and the environment, and for facilitating the review and regulation of nanotechnology-based materials and products. They are therefore one of the foundational components that enable effective assessment of products created with nanomaterials, as well as development of associated policies and best practices to protect the people who manufacture, work with, and use those materials.”

Work in Progress for Health and Safety Standards

ISO TC 229’s standard-setting activities are assigned to four Working Groups (WGs). Responsibility for the development of science-based standards for the safe development and use of nanotechnologies falls to WG 3, Health, Safety and Environment. Operating under the leadership of Steven Brown of Intel Corporation (USA), the group has become a focal point for nanotechnology safety experts.

Representatives from seventeen of TC 229’s thirty participating national bodies are active in the work of the WG. Several other internationally-recognized bodies participate as liaisons to the committee, including: the European Committee for Standardization (CEN) TC 352, Nanotechnologies; the European Commission Joint Research Centre (EC-JRC); and the Organisation for Economic Co-Operation and Development Working Party on Manufactured Nanomaterials (OECD WPMN).

Its workload is heavy, with five active projects and a proposed sixth work item now under consideration.

As announced in last month’s article, the WG’s most mature document, a guidance document that provides critical information on occupational safety for those involved in the manufacture and use of nanomaterials in the workplace, was recently finalized.

Publication of the report, entitled Health and safety practices in occupational settings relevant to nanotechnologies, is anticipated by year-end 2008.

“This technical report will serve as a foundation for responsible national nanotechnology occupational safety and health programs worldwide,” said Vladimir Murashov, special assistant on nanotechnology to the director of the National Institute for Occupational Safety and Health (NIOSH), and the project leader for this initiative.

The report builds on guidance originally provided by NIOSH, the federal agency responsible for conducting research and making recommendations for the prevention of work-related injury and illness.

Japan and South Korea have also stepped forward in leadership roles, serving as project leaders for three of the WG’s other active projects:

Endotoxin test on nanomaterial samples for in vitro systems;
Generation of nanoparticles for inhalation toxicity texting; and
Monitoring nanoparticles in inhalation exposure chambers for inhalation toxicity testing.
The fifth – and newest – WG 3 work item, Guidance on physico-chemical characterization of engineered nano-objects for toxicologic assessment, will serve as a reference for characterizing nano-objects for toxicology testing. The United States, under the leadership of Dr. Richard C. Pleus (Intertox) is spearheading this effort.

How to Participate

For each ISO Technical Committee or Subcommittee where the U.S. is a participating member, ANSI accredits a Technical Advisory Group (TAG) to develop and transmit our national positions on standards proposals and related activities. In the case of nanotechnology activities within ISO, one U.S. TAG, supported by multiple working groups, determines U.S. positions and advocates those positions at ISO

Dr. Laurie Locascio of the National Institute of Standards and Technology (NIST) chairs the U.S. ISO/TC 229 TAG Working Group on Health, Safety and Environment. Members of the TAG WG include representatives of academia, government, standards developing organizations, and industry. With this expert input, the TAG WG prepares the U.S. position for WG 3 issues, recommends future work items, and considers proposals from other national bodies.

“With Steve Brown’s leadership of the WG, and the active participation of our TAG members, the U.S. has the ability to help set the pace of nanotechnology standardization for health, safety, and the environment,” said Dr. Locascio. “Developing standards in this area will have a powerful impact on our ability to move this technology platform forward in a responsible manner.”

Participation in the U.S. ISO/TC 229 TAG Working Group is open to all nationally interested stakeholders, and the TAG actively seeks participants who have expert knowledge in all aspects of nanotechnology as it relates to health, safety, and the environment. To join the U.S. TAG for ISO/TC 229 or any of its WGs, contact Heather Benko (hbenko@ansi.org; 212.642.4912).

For more information on the U.S. TAG for ISO/TC 229, visit www.ansi.org/iscotc229tag.

Stay Tuned: The next article in this series will introduce ISO/TC 229/WG 1, Terminology and nomenclature.

New Report: Nanotechnologies for Energy and the Environment

Research and Market recently announced the publication of a new report addressing environmental uses and applications of nanomaterials.  The report covers many applications, environmental media, and toxicology, and, "describes nanotechnologies, nanomaterials, nanotechnology companies, universities and research centers related to nanotechnologies for new environmental technologies.  Areas covered by are leading edge research in emission reduction, environmental remediation and monitoring, green manufacturing, water filtration and treatment, energy conversion and storage, alternative energy and toxicology. "

The table of contents of the report is available here, and the full report can be purchased for EUR 1,584 (approximately $2,100.00).
 

Environmental Benefits of Nanotechnology

A recent article by Nanowerk highlights the sometimes overlooked environmental benefits that nanotechnology may provide.  While much focused is placed on the environmental, health, and safety impacts that free nanomaterials may create, very little mainstream discussion concerns the benefits that are being researched.

The Nanowerk article mentions programs in Europe that have the affect of monitoring or preventing pollution, such as self-cleaning paints and "anti-fouling" coatings.  Further, there are at least four sites in the United States, and an at least two in Canada, using nanomaterials on an experimental basis to test groundwater remediation. 

These kinds of advances in environmental protection and remediation should not be lost in the discussion over the possible impacts of nanotechnology.  It is important to keep in mind that while there is potential for unintended impacts, nanotechnology can have many uses, including maintaining and supporting environmental health.

Summary -- ABA Nanotechnology Seminar

AUTHORED BY ANDREW BERGMAN

On October 27, 2006, the ABA Section on Environment, Energy and Resources sponsored a teleconference on the science of nanotechnology.  The speakers were Kristen Kulinowski, Ph.D., from Rice University, and John Balbus, M.D., from Environmental Defense, and the moderator was Sunil Garg, Ph.D., Esq., from the Ecoshelf Group.

Kulinowski described nanotechnology as understanding and controlling of matter between the molecular and particulate levels, where the properties of materials change and new properties emerge. For example, gold at nanoscale is red or blue and has a much higher chemical reactivity.  Major changes can be made to a material's magnetism, friction and electrical conductivity. There are already 200-300 products on the market today that are touted as nanomaterials, and success is predicted for nanomaterials with regard to solar panels, replacing copper wires, defense applications, medicine and environmental technology. However, nanomaterials cause come concern. Some materials appear to be fairly cytotoxic, and larger cell organisms show the effects of nanomaterials in hazard studies (inject in lab).

 Exposure studies lag being hazard studies. Evaluating nanomaterials is difficult because they are extremely diverse; a limitless capacity to create such materials leads to no overarching framework of potential hazards. So far analytical tools are poorly developed for understanding risk so beware of over generalizing nanomaterial behavior, either good or bad. Current barriers to understanding risk include (1) lack of strategic research, (2) lack of standards, (3) uncertain regulatory environment, (4) transparency and responsiveness of public concerns, and (5) lack of sufficient funding. However, the International Council on Nanotechnology is developing a database of technical material and is releasing a survey of how firms handle nanomaterials on Nov. 13 (will be available on their website). Predictions for 2007: increased pressure on regulatory agencies to understand how nanotechnology fits into existing statutes and regs, increased call for labeling of consumer products, development of the research framework for evaluating risk, new standards for workplace handling, and better evaluation of potential risks.

Balbus agreed with much of what Kulinowski's comments. Nanomaterials hold great promise as solutions to energy and health issues so the challenge is to achieve the benefits without repeating past mistakes re risk. For the discussion of potential risks, analogize to combustion particles, fine and ultra fine, because we know about their serious health effects. Particles can get through physiological barriers so enter the blood system and be taken up into cells by different mechanisms. They also can pick up unwanted other toxic materials and so deliver secondary particles. We are at early stages in understanding risk; the approach so far has been to analogize to larger particles, hypothesize using computer models, and conduct actual studies. Some studies have been reassuring but others had surprising results such as the evidence of direct stimulatory effect on cells and increased water solubility. We also have gaps in our understanding of bioaccumulation: do these materials accumulate in the body or are they secreted? Are they mobile in the environment or do they breakdown? How interact with critical cells and molecules? What are their structural activity relationships (i.e. how surface characteristics relate to toxicity? What about chronic toxicity? Difficult to make strong conclusions about toxicity of nanoparticles at this time. Reasons for a gaps in understanding: (1) infinite variation, (2) expensive to get enough material for long-term studies, (3) need instruments to detect and measure, and (4) materials tend to clump together so hard to recreate actual exposure situations. Need to develop a risk management framework. Existing regulatory coverage uncertain so companies are doing more to avoid liability than to meet existing regs; a document will be released in 2007 on Dupont's attempts to manage risk. Need more investment to research risk, need transparency in research, and need proactive stance by regulatory agencies.

Points made during question and answer. Concerns over lack of standards or guidelines for labeling consumer products. Concerns over the harmonization of international efforts over terminology and nomenclature, and standards for handling. Not sure how the REACH regime in Europe will apply to nanotechnology. Two efforts at voluntary standards: ASTM document out soon (protocol for minimizing exposure) and ISO document out later. Top research priorities: instrumentation and monitoring equipment, bioaccumulation and transport, and exposure to consumers and the environment.